ID   LNISi001-B
AC   CVCL_D6IT
DR   hPSCreg; LNISi001-B
DR   Wikidata; Q127382617
RX   PubMed=37875964;
CC   From: Laboratory of NeuroImmunology, Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IS ! LNISi001-A
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=37875964; DOI=10.1186/s12987-023-00479-4; PMCID=PMC10598911;
RA   Studle, Chiara
RA   Nishihara, Hideaki
RA   Wischnewski, Sven
RA   Kulsvehagen, Laila
RA   Perriot, Sylvain
RA   Ishikawa, Hiroshi
RA   Schroten, Horst
RA   Frank, Stephan
RA   Deigendesch, Nikolaus
RA   Du Pasquier, Renaud
RA   Schirmer, Lucas
RA   Probstel, Anne-Katrin
RA   Engelhardt, Britta
RT   "SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid
RT   barrier rather than endothelial cells or pericytes of the blood-brain
RT   barrier.";
RL   Fluids Barriers CNS 20:76.1-76.21(2023).
//